Taldefgrobep
Taldefgrobep Alfa in Adults With Overweight and Obesity
Biohaven Therapeutics · Phase 2 · Active, not recruiting · Enrollment 150
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Taldefgrobep Alpha once weekly | n/r | n/r | n/r | n/r | n/r |
| Placebo once weekly | n/r | n/r | n/r | n/r | n/r |
| Taldefgrobep Alpha once every 4 weeks | n/r | n/r | n/r | n/r | n/r |
| Placebo once every 4 weeks | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.